Chronic kidney disease in older people with intellectual disability: results of the HA-ID study

C F de Winter1, M A Echteld2, H M Evenhuis2

  • 1Intellectual Disability Medicine, Erasmus Medical Center Rotterdam, Department of General Practice, Rotterdam, The Netherlands; Reinaerde, Den Dolder, The Netherlands.

Insights

Chronic kidney disease affects 15.3% of older adults with intellectual disability (ID), similar to the general population. Early GFR measurement is recommended for those with ID, especially with sarcopenia or Down syndrome.

Area of Science:

  • Gerontology
  • Nephrology
  • Intellectual Disability Research

Background:

  • Aging populations and increased cardiovascular events necessitate understanding chronic kidney disease (CKD) in older adults with intellectual disability (ID).
  • Previous research has not fully elucidated CKD prevalence and associated factors in this specific demographic.

Purpose of the Study:

  • To determine the prevalence and associations of CKD in individuals aged 50 and over with ID.
  • To investigate the impact of sarcopenia on CKD prevalence estimation using different glomerular filtration rate (GFR) equations.

Main Methods:

  • Cross-sectional study (Healthy Ageing and Intellectual Disability - HA-ID) of 635 Dutch adults with ID aged 50+.
  • Plasma creatinine and cystatin-C measurements to calculate GFR using MDRD and CKD-EPI equations.
  • Analysis of CKD prevalence in participants with and without sarcopenia, comparing GFR estimation methods.

Main Results:

  • Overall CKD prevalence was 15.3%, comparable to the general Dutch population.
  • CKD was associated with older age, Down syndrome, obesity, hypercholesterolemia, and hypothyroid disease.
  • In sarcopenic individuals, CKD-EPI (creatinine and cystatin-C) indicated higher prevalence than MDRD, though with wide confidence intervals.

Conclusions:

  • CKD prevalence in older adults with ID is similar to the general population.
  • Regular GFR monitoring is advised for older adults with ID, particularly those with polypharmacy or Down syndrome.
  • For individuals with ID and sarcopenia, GFR assessment should incorporate cystatin-C alongside creatinine to improve accuracy.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.4K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
706
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
358
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
702
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
582